{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:25Z","timestamp":1707523945650},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,24]]},"DOI":"10.7759\/cureus.44050","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:51:32Z","timestamp":1692895892000},"source":"Crossref","is-referenced-by-count":0,"title":["Visceral Leishmaniasis With Blastocystis Co-infection: A Case Report"],"prefix":"10.7759","author":[{"given":"Tengfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby","family":"Rampisela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2015-0002","article-title":"Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment","volume":"3","author":"Georgiadou SP","year":"2015","unstructured":"Georgiadou SP, Makaritsis KP, Dalekos GN. Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment. J Transl Int Med. 2015, 3:43-50. 10.1515\/jtim-2015-0002","journal-title":"J Transl Int Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109059","article-title":"Unwelcome prevalence of leishmaniasis with several other infectious diseases","volume":"110","author":"Saini I","year":"2022","unstructured":"Saini I, Joshi J, Kaur S. Unwelcome prevalence of leishmaniasis with several other infectious diseases. Int Immunopharmacol. 2022, 110:109059. 10.1016\/j.intimp.2022.109059","journal-title":"Int Immunopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030578","article-title":"Leishmaniasis in the United States: emerging issues in a region of low endemicity","volume":"9","author":"Curtin JM","year":"2021","unstructured":"Curtin JM, Aronson NE. Leishmaniasis in the United States: emerging issues in a region of low endemicity. Microorganisms. 2021, 9:10.3390\/microorganisms9030578","journal-title":"Microorganisms"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06815-z","article-title":"Prevalence, subtypes and risk factors of Blastocystis spp. infection among pre- and perimenopausal women","volume":"21","author":"Kosik-Bogacka D","year":"2021","unstructured":"Kosik-Bogacka D, Lepczy\u0144ska M, Kot K, Szkup M, \u0141anocha-Arendarczyk N, Dzika E, Grochans E. Prevalence, subtypes and risk factors of Blastocystis spp. infection among pre- and perimenopausal women. BMC Infect Dis. 2021, 21:1125. 10.1186\/s12879-021-06815-z","journal-title":"BMC Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/239469","article-title":"Developments in diagnosis of visceral leishmaniasis in the elimination era","volume":"2015","author":"Singh OP","year":"2015","unstructured":"Singh OP, Sundar S. Developments in diagnosis of visceral leishmaniasis in the elimination era. J Parasitol Res. 2015, 2015:239469. 10.1155\/2015\/239469","journal-title":"J Parasitol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.12.024","article-title":"Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host","volume":"17","author":"Saporito L","year":"2013","unstructured":"Saporito L, Giammanco GM, De Grazia S, Colomba C. Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host. Int J Infect Dis. 2013, 17:e572-6. 10.1016\/j.ijid.2012.12.024","journal-title":"Int J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01387-17","article-title":"The brief case: the unexpected souvenir","volume":"56","author":"Asbury K","year":"2018","unstructured":"Asbury K, Seville MT, Pritt B, Scotch A, Rosenthal A, Grys TE, Kelemen K. The brief case: the unexpected souvenir. J Clin Microbiol. 2018, 56:10.1128\/JCM.01387-17","journal-title":"J Clin Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1590\/s0037-86822010000400010","article-title":"Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study","volume":"43","author":"Costa CH","year":"2010","unstructured":"Costa CH, Werneck GL, Costa DL, et al.. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev Soc Bras Med Trop. 2010, 43:386-92. 10.1590\/s0037-86822010000400010","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref9","article-title":"Chronic diarrhea and malabsorption caused by Leishmania donovani","volume":"25","author":"Baba CS","year":"2006","unstructured":"Baba CS, Makharia GK, Mathur P, Ray R, Gupta SD, Samantaray JC. Chronic diarrhea and malabsorption caused by Leishmania donovani. Indian J Gastroenterol. 2006, 25:309-10.","journal-title":"Indian J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10101887","article-title":"Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics","volume":"10","author":"Scarpini S","year":"2022","unstructured":"Scarpini S, Dondi A, Totaro C, et al.. Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics. Microorganisms. 2022, 10:10.3390\/microorganisms10101887","journal-title":"Microorganisms"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson N","year":"2016","unstructured":"Aronson N, Herwaldt BL, Libman M, et al.. Diagnosis and treatment of leishmaniasis: clinical practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016, 63:e202-64. 10.1093\/cid\/ciw670","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1999.tb01817.x","article-title":"Immunohistochemistry to identify Leishmania parasites in fixed tissues","volume":"26","author":"Kenner JR","year":"1999","unstructured":"Kenner JR, Aronson NE, Bratthauer GL, Turnicky RP, Jackson JE, Tang DB, Sau P. Immunohistochemistry to identify Leishmania parasites in fixed tissues. J Cutan Pathol. 1999, 26:130-6. 10.1111\/j.1600-0560.1999.tb01817.x","journal-title":"J Cutan Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_338_19","article-title":"An unusual presentation of post kala-azar dermal Leishmaniasis","volume":"11","author":"Pathania S","year":"2020","unstructured":"Pathania S, Kumari P, Suvirya S, Chakravarty J. An unusual presentation of post kala-azar dermal Leishmaniasis. Indian Dermatol Online J. 2020, 11:269-71. 10.4103\/idoj.IDOJ_338_19","journal-title":"Indian Dermatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.3.382","article-title":"Detection of infection or infectious agents by use of cytologic and histologic stains","volume":"9","author":"Woods GL","year":"1996","unstructured":"Woods GL, Walker DH. Detection of infection or infectious agents by use of cytologic and histologic stains. Clin Microbiol Rev. 1996, 9:382-404. 10.1128\/CMR.9.3.382","journal-title":"Clin Microbiol Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1590\/S1678-9946201961025","article-title":"Evaluation of the diagnostic potential of CD1a immunohistochemistry for visceral leishmaniasis","volume":"61","author":"Gadelha SA","year":"2019","unstructured":"Gadelha SA, Cunha MD, Coelho GM, Marinho TM, Hirth CG. Evaluation of the diagnostic potential of CD1a immunohistochemistry for visceral leishmaniasis. Rev Inst Med Trop Sao Paulo. 2019, 61:e25. 10.1590\/S1678-9946201961025","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002982","article-title":"Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysis","volume":"8","author":"Belo VS","year":"2014","unstructured":"Belo VS, Struchiner CJ, Barbosa DS, Nascimento BW, Horta MA, da Silva ES, Werneck GL. Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysis. PLoS Negl Trop Dis. 2014, 8:e2982. 10.1371\/journal.pntd.0002982","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21608\/eajbse.2022.231586","article-title":"The possible involvement of protozoans in causing cancer in human","volume":"14","author":"Salim M","year":"2022","unstructured":"Salim M, Mohammad Shahid M, Shagufta P. The possible involvement of protozoans in causing cancer in human. Egypt Acad J Biol Sci, E Med Entomol Parasitol. 2022, 14:71-86. 10.21608\/eajbse.2022.231586","journal-title":"Egypt Acad J Biol Sci, E Med Entomol Parasitol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.563","article-title":"Blastocystis hominis revisited","volume":"9","author":"Stenzel DJ","year":"1996","unstructured":"Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev. 1996, 9:563-84. 10.1128\/CMR.9.4.563","journal-title":"Clin Microbiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2011.10-0447","article-title":"Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of blastocystis sp. in clinical stool samples","volume":"84","author":"Roberts T","year":"2011","unstructured":"Roberts T, Barratt J, Harkness J, Ellis J, Stark D. Comparison of microscopy, culture, and conventional polymerase chain reaction for detection of blastocystis sp. in clinical stool samples. Am J Trop Med Hyg. 2011, 84:308-12. 10.4269\/ajtmh.2011.10-0447","journal-title":"Am J Trop Med Hyg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.29.1800546","article-title":"Dientamoeba fragilis - the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017","volume":"24","author":"Pietil\u00e4 JP","year":"2019","unstructured":"Pietil\u00e4 JP, Meri T, Siikam\u00e4ki H, et al.. Dientamoeba fragilis - the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017. Euro Surveill. 2019, 24:10.2807\/1560-7917.ES.2019.24.29.1800546","journal-title":"Euro Surveill"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/tp.tp_93_21","article-title":"Evaluation of microscopy and PCR for detection of Dientamoeba fragilis","volume":"12","author":"Tolba MM","year":"2022","unstructured":"Tolba MM, Allam AF, Khalil SS, Elshouki WM, Shehab AY. Evaluation of microscopy and PCR for detection of Dientamoeba fragilis. Trop Parasitol. 2022, 12:87-93. 10.4103\/tp.tp_93_21","journal-title":"Trop Parasitol"},{"key":"ref22","article-title":"Serologic response to Blastocystis hominis infection in asymptomatic individuals","volume":"25","author":"Kaneda Y","year":"2000","unstructured":"Kaneda Y, Horiki N, Cheng X, Tachibana H, Tsutsumi Y. Serologic response to Blastocystis hominis infection in asymptomatic individuals. Tokai J Exp Clin Med. 2000, 25:51-6.","journal-title":"Tokai J Exp Clin Med"},{"key":"ref23","article-title":"Secretory and humoral antibody responses to Blastocystis hominis in symptomatic and asymptomatic human infections","volume":"33","author":"Mahmoud MS","year":"2003","unstructured":"Mahmoud MS, Saleh WA. Secretory and humoral antibody responses to Blastocystis hominis in symptomatic and asymptomatic human infections. J Egypt Soc Parasitol. 2003, 33:13-30.","journal-title":"J Egypt Soc Parasitol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac143","article-title":"Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial","volume":"30","author":"Cobuccio LG","year":"2023","unstructured":"Cobuccio LG, Laurent M, Gardiol C, et al.. Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial. J Travel Med. 2023, 30:10.1093\/jtm\/taac143","journal-title":"J Travel Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007444","article-title":"Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India","volume":"13","author":"Lappan R","year":"2019","unstructured":"Lappan R, Classon C, Kumar S, et al.. Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India. PLoS Negl Trop Dis. 2019, 13:e0007444. 10.1371\/journal.pntd.0007444","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178339-visceral-leishmaniasis-with-blastocystis-co-infection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:25Z","timestamp":1707508525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178339-visceral-leishmaniasis-with-blastocystis-co-infection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.44050","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}